908 related articles for article (PubMed ID: 26084021)
1. Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation.
Molofsky AB; Savage AK; Locksley RM
Immunity; 2015 Jun; 42(6):1005-19. PubMed ID: 26084021
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine.
Cayrol C; Girard JP
Cytokine; 2022 Aug; 156():155891. PubMed ID: 35640416
[TBL] [Abstract][Full Text] [Related]
3. IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease.
Perez F; Ruera CN; Miculan E; Carasi P; Dubois-Camacho K; Garbi L; Guzman L; Hermoso MA; Chirdo FG
Front Immunol; 2020; 11():581445. PubMed ID: 33133101
[TBL] [Abstract][Full Text] [Related]
4. IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection.
Zeng S; Wu J; Liu J; Qi F; Liu B
Scand J Immunol; 2015 Jun; 81(6):494-501. PubMed ID: 25721734
[TBL] [Abstract][Full Text] [Related]
5. Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation.
Takatori H; Makita S; Ito T; Matsuki A; Nakajima H
Front Immunol; 2018; 9():2004. PubMed ID: 30233590
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
7. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.
Smithgall MD; Comeau MR; Yoon BR; Kaufman D; Armitage R; Smith DE
Int Immunol; 2008 Aug; 20(8):1019-30. PubMed ID: 18550585
[TBL] [Abstract][Full Text] [Related]
8. Effector and regulatory T cell subsets in diabetes-associated inflammation. Is there a connection with ST2/IL-33 axis? Perspective.
Ryba-Stanisławowska M; Stanisławowski M; Myśliwska J
Autoimmunity; 2014 Sep; 47(6):361-71. PubMed ID: 24547981
[TBL] [Abstract][Full Text] [Related]
9. IL-33 and the intestine: The good, the bad, and the inflammatory.
Hodzic Z; Schill EM; Bolock AM; Good M
Cytokine; 2017 Dec; 100():1-10. PubMed ID: 28687373
[TBL] [Abstract][Full Text] [Related]
10. IL-33/ST2 axis in inflammation and immunopathology.
Milovanovic M; Volarevic V; Radosavljevic G; Jovanovic I; Pejnovic N; Arsenijevic N; Lukic ML
Immunol Res; 2012 Apr; 52(1-2):89-99. PubMed ID: 22392053
[TBL] [Abstract][Full Text] [Related]
11. New dog and new tricks: evolving roles for IL-33 in type 2 immunity.
Lott JM; Sumpter TL; Turnquist HR
J Leukoc Biol; 2015 Jun; 97(6):1037-48. PubMed ID: 25801770
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
Cayrol C; Girard JP
Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993
[TBL] [Abstract][Full Text] [Related]
13. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation.
Hayakawa H; Hayakawa M; Kume A; Tominaga S
J Biol Chem; 2007 Sep; 282(36):26369-80. PubMed ID: 17623648
[TBL] [Abstract][Full Text] [Related]
14. IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases.
Vocca L; Di Sano C; Uasuf CG; Sala A; Riccobono L; Gangemi S; Albano GD; Bonanno A; Gagliardo R; Profita M
Immunobiology; 2015 Aug; 220(8):954-63. PubMed ID: 25747940
[TBL] [Abstract][Full Text] [Related]
15. IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells.
Matta BM; Lott JM; Mathews LR; Liu Q; Rosborough BR; Blazar BR; Turnquist HR
J Immunol; 2014 Oct; 193(8):4010-20. PubMed ID: 25217167
[TBL] [Abstract][Full Text] [Related]
16. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.
Pecaric-Petkovic T; Didichenko SA; Kaempfer S; Spiegl N; Dahinden CA
Blood; 2009 Feb; 113(7):1526-34. PubMed ID: 18955562
[TBL] [Abstract][Full Text] [Related]
17. Lung ILC2s link innate and adaptive responses in allergic inflammation.
Martinez-Gonzalez I; Steer CA; Takei F
Trends Immunol; 2015 Mar; 36(3):189-95. PubMed ID: 25704560
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells.
Allakhverdi Z; Smith DE; Comeau MR; Delespesse G
J Immunol; 2007 Aug; 179(4):2051-4. PubMed ID: 17675461
[TBL] [Abstract][Full Text] [Related]
19. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
Schmitz J; Owyang A; Oldham E; Song Y; Murphy E; McClanahan TK; Zurawski G; Moshrefi M; Qin J; Li X; Gorman DM; Bazan JF; Kastelein RA
Immunity; 2005 Nov; 23(5):479-90. PubMed ID: 16286016
[TBL] [Abstract][Full Text] [Related]
20. ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma.
Jovanovic I; Radosavljevic G; Mitrovic M; Juranic VL; McKenzie AN; Arsenijevic N; Jonjic S; Lukic ML
Eur J Immunol; 2011 Jul; 41(7):1902-12. PubMed ID: 21484786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
